Skip to content

The dynamic effects of hypertension on the brain and its vessels

The dynamic effects of hypertension on the brain and its vessels - DynaBrain

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45503
Enrollment
200
Registered
2018-01-01
Start date
2018-08-15
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Diurnal fluctuations
Hypertension
Magnetic resonance imaging

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with hypertension: • 18 years and older • Hypertension >140/90 mm Hg at inclusion. • Patients must be part of the *zorgpad hypertensie*. These patients are temporary drug naïve and are switched on to medication after two weeks of being drug naïve as part of this *zorgpad hypertensie*.;Inclusion criteria for healthy volunteers: • 18 years and older

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with hypertension: • Impossibility to undergo MRI (claustrophobia, implants or metal objects in or around the body) • Pregnancy • Non-Dutch speaking • Illiterate;Exclusion criteria for healthy volunteers: • Impossibility to undergo MRI (claustrophobia, implants or metal objects in or around the body) • Pregnancy • Treated with antihypertensive medication • Non-Dutch speaking • illiterate

Design outcomes

Primary

MeasureTime frame
The main study parameters are the structural and functional MRI differences between baseline and follow-up scans (both 3T and 7T MRI).

Secondary

MeasureTime frame
The secondary study parameters are the structural and functional MRI differences between patients and healthy volunteers. The tertiary study parameters are the difference between morning and evening total brain volumes, CSF volumes, and perfusion status as measured with 3T MRI. The quaternary study parameter/endpoint is the clinical consequences of hypertension as measured with neuropsychological tests.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)